Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-26 7:57 pm Sale | 2024-03-22 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 2,813,837 5.400% | -834,459 (-22.87%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2024-01-30 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 3,648,296 6.900% | 171,215 (+4.92%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | Citadel Advisors LLC | 43,447 0.100% | -1,948,106 (-97.82%) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 5,450,000 12.300% | 448,217 (+8.96%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-06-14 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 5,001,783 11.300% | 2,658,926 (+113.49%) | Filing History |
| 2024-02-14 3:21 pm Unchanged | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | Ares Trading S.A. | 1,913,501 3.600% | 0 (Unchanged) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | Kynam Capital Management, LP | 3,650,339 8.220% | 2,241,241 (+159.06%) | Filing History |
| 2024-02-12 4:38 pm Purchase | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | Woodline Partners LP | 1,140,632 2.200% | 1,140,632 (New Position) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | VERA THERAPEUTICS INC VERA | FMR LLC | 2,774,372 6.243% | -533,238 (-16.12%) | Filing History |
| 2024-02-05 4:45 pm Purchase | 2024-02-01 | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV, LLC | 5,164,062 9.800% | 9,925 (+0.19%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | VERA THERAPEUTICS INC VERA | BlackRock, Inc. BLK | 2,754,894 6.200% | 2,754,894 (New Position) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | VERA THERAPEUTICS INC VERA | FMR LLC | 3,307,610 7.463% | -841,036 (-20.27%) | Filing History |
| 2023-08-02 5:01 pm Sale | 2023-07-18 | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group, Inc. CG | 1,872,764 4.200% | -544,073 (-22.51%) | Filing History |
| 2023-07-05 4:17 pm Sale | 2023-06-28 | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group, Inc. CG | 2,416,837 5.500% | -543,394 (-18.36%) | Filing History |
| 2023-04-13 4:06 pm Sale | 2023-03-28 | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group, Inc. CG | 2,960,231 6.700% | -9,925 (-0.33%) | Filing History |
| 2023-02-16 4:40 pm Purchase | 2023-02-06 | 13D | VERA THERAPEUTICS INC VERA | Longitude Capital Partners IV, LLC | 5,154,137 12.300% | 1,714,285 (+49.84%) | Filing History |
| 2023-02-16 4:05 pm Purchase | 2023-02-06 | 13G | VERA BRADLEY, INC VRA | Commodore Capital LP | 2,342,857 5.600% | 2,342,857 (New Position) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | VERA THERAPEUTICS INC VERA | RA Capital Management, L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | VERA THERAPEUTICS INC VERA | Citadel Advisors LLC | 1,991,553 7.200% | -50,867 (-2.49%) | Filing History |
| 2023-02-13 8:43 pm Purchase | 2023-02-06 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 3,477,081 8.300% | 285,714 (+8.95%) | Filing History |